TABLE 1.
Straina | CQ 50% inhibitory concn (nM)b | Verapamil effectc | Resting vacuolar [Ca2+] (μM)b |
---|---|---|---|
TM6 | 93 ± 7 | Yes | 1.68 ± 0.97 |
3D7 | 8 ± 2 | No | 2.34 ± 0.35 |
C3Dd2 | 50 ± 3 | Yes | 1.84 ± 0.71 |
C2GCO3 | 10 ± 3 | No | 1.93 ± 0.28 |
D10D10 | 23 ± 2 | No | 1.95 ± 0.10 |
D107G8 | 16 ± 2 | No | 2.12 ± 0.60 |
TM6 is a laboratory-adapted CQ-resistant strain; 3D7 is a laboratory-adapted CQ-sensitive strain. In clone C3dd2, the pfcrt allele of a CQ-sensitive clone (GCO3) has been replaced by the pfcrt allele of the CQ-resistant clone Dd2 (14). In clone C2GCO3, the sensitive pfcrt allele from a CQ-sensitive clone has been replaced by another CQ-sensitive pfcrt allele (14) (as a control for any basal effect of pfcrt allelic exchange). In clone D10D10, the pfmdr allele from a CQ-sensitive isolate (D10) was replaced by the pfmdr allele from the same CQ-sensitive clone (11). In clone D107G8, the pfmdr allele from a CQ-sensitive clone (D10) was replaced with a pfmdr allele from a CQ-resistant clone (7G8) (11).
Values represent means ± standard error from at least three independent measurements.
Ability of verapamil (5 μM) to chemosensitize the parasite clone to CQ (8).